Új vizsgálatok, publikációk, preprintek és pályázatok ezen a célponton, hónapról hónapra.
Publikáció
Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants.
2026. nov. 5.· PLoS genetics· PUBMED
Publikáció
Histology-dependent coupling of TERT to the proliferation programme statistically accounts for much of the between-cohort heterogeneity in DNMT3B-TERT co-expression in oesophageal carcinoma: a 27-cohort meta-analysis and pan-cancer re-analysis.
2026. okt. 31.· Functional & integrative genomics· PUBMED
Publikáció
Restoration of radioiodine avidity after lenvatinib in NRAS- and TERT promoter-mutant radioiodine-refractory differentiated thyroid cancer: a case report.
2026. okt. 30.· EJNMMI reports· PUBMED
Publikáció
AKT1-phosphorylated TERT assembles a FOXO3-MYC transcriptional complex that drives ERphagy and proteostasis in post-mitotic RPE.
2026. okt. 26.· Autophagy· PUBMED
Publikáció
Correction to: "BRAF-induced EHF Expression Affects TERT in Aggressive Papillary Thyroid Cancer".
2026. okt. 16.· The Journal of clinical endocrinology and metabolism· PUBMED
Publikáció
Isolated TERT promoter mutation may define a high-risk prognostic subgroup in papillary thyroid carcinoma: an exploratory, hypothesis-generating analysis of TCGA and GSE33630 datasets.
2026. okt. 15.· Frontiers in endocrinology· PUBMED
Publikáció
CDKN2A deletion associated with poor prognosis in patients with TERT promoter wild-type, IDH wild-type glioblastoma.
2026. okt. 10.· Brain tumor pathology· PUBMED
Publikáció
TERT is a therapeutic target for tertiary stroke prevention.
2026. okt. 9.· Journal of advanced research· PUBMED
Publikáció
TERT reactivation in thyroid cancer: mechanisms, clinical implications, and therapeutic opportunities.
2026. okt. 1.· European thyroid journal· PUBMED
Publikáció
TERT promoter mutations in papillary thyroid carcinoma: association with gross extrathyroidal invasion and outcomes.
2026. okt. 1.· European thyroid journal· PUBMED
Publikáció
TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.
2026. okt. 1.· JAMA otolaryngology-- head & neck surgery· PUBMED
Publikáció
Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.
2026. szept. 30.· Frontiers in oncology· PUBMED
Publikáció
FOXE1, IMP-3, and TERT expressions in papillary thyroid carcinomas.
2026. szept. 28.· Indian journal of pathology & microbiology· PUBMED
Publikáció
SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.
2026. szept. 28.· Neuro-oncology· PUBMED
Publikáció
LncRNA 34962 drives pulmonary vascular remodeling in pulmonary hypertension due to left heart disease through the miR-3575/cMYC/TERT signaling axis.
2026. szept. 24.· European journal of pharmacology· PUBMED
Publikáció
Multiparametric static hybrid ¹⁸F-FET PET/MR for preoperative prediction of TERT promoter mutation in glioblastoma.
2026. szept. 9.· Neuroradiology· PUBMED
Publikáció
Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors.
2026. szept. 1.· Anticancer research· PUBMED
Publikáció
A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred - A case series.
2026. aug. 31.· Therapeutic advances in respiratory disease· PUBMED
Publikáció
USP53-ALKBH5 axis inhibition boosts m6A-modified TERT RNA degradation: A potential therapeutic strategy for glioblastoma.
2026. aug. 15.· Biochimica et biophysica acta. Molecular basis of disease· PUBMED
Publikáció
Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation.
2026. aug. 14.· Neurosurgical review· PUBMED
Publikáció
TERT Promoter Mutations Are Preferentially Associated With the ERBB2 G776-Altered Subtype of HER2-Mutant NSCLC.
2026. aug. 13.· Cancer science· PUBMED
Publikáció
Value of TERT promoter mutations for early outcomes in papillary thyroid cancer.
2026. aug. 1.· Endocrine-related cancer· PUBMED
Publikáció
Par-4/TERT induced autophagy dysregulation in regulating glycolysis in hyperglycemia combined with hepatocellular carcinoma.
2026. júl. 31.· Journal of bioenergetics and biomembranes· PUBMED
Publikáció
Correction: Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma.
2026. júl. 22.· Frontiers in endocrinology· PUBMED
Publikáció
BRAF V600E/TERT Promoter Co-Mutation Is Associated with Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Translational Molecular Biomarker Study.
2026. júl. 20.· Biomedicines· PUBMED
Publikáció
Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan.
2026. júl. 20.· PloS one· PUBMED
Publikáció
PACT Inhibits Malignant Biological Behavior of Ovarian Cancer Cells by Regulating TERT Expression.
2026. júl. 16.· Molecular carcinogenesis· PUBMED
Publikáció
TERT drives liver tumorigenesis beyond telomere elongation.
2026. júl. 2.· Life science alliance· PUBMED
Publikáció
CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells.
2026. jún. 24.· Cells· PUBMED
Publikáció
[shRNA-mediated downregulation of TERT inhibits melanoma in vitro and in vivo].
2026. jún. 23.· Zhonghua zhong liu za zhi [Chinese journal of oncology]· PUBMED